Alberta Children Hospital

Dr. Kirton is an Associate Professor of Pediatrics and Clinical Neurosciences at the University of Calgary as well as an Attending Pediatric Neurologist at the Alberta Children's Hospital. His perinatal stroke research has two main objectives. One is to comprehend the causes of such strokes and create strategies for preventing them. The other measures how the growing brain reacts to an early injury and develops novel treatments using cutting-edge technology like neuroimaging and non-invasive brain stimulation. Dr. Kirton received support from the CIHR Foundations in 2015 and is a clinician scientist for the Heart and Stroke Foundation. He established and oversees the ACH Pediatric Non-Invasive Brain Stimulation Laboratory, the Calgary Pediatric Stroke Program, and the Alberta Perinatal Stroke Initiative. View Profile

At the University of Alberta in Canada, Dr. Riva-Cambrin started his medical education. At the University of Toronto in Canada, he finished his residency after earning his medical degree there in June 1998. Under the guidance of Dr. James Drake, he earned a Masters of Science in Clinical Epidemiology from the University of Toronto. At The Hospital for Sick Children, University of Toronto in Pediatric Neurosurgery, Dr. Riva-Cambrin finished a postgraduate residency in paediatric neurological surgery. Clinical trials and the treatment of hydrocephalus are two areas in paediatric neurosurgery where Dr. Riva-Cambrin has interests. He belongs to the Network for Clinical Research on Hydrocephalus (HCRN). He created a model that anticipates hydrocephalus in children with tumours. 100 of the roughly 250 neurosurgeries Dr. Riva-Cambrin conducts each year are for hydrocephalus. In addition to serving as the Program Director for the Pediatric Neurosurgery Fellowship Program and an Assistant Professor in the Department of Neurosurgery at the University of Utah and Primary Children's Hospital Center, Dr. Riva-Cambrin joined the faculty in 2006. View Profile

General surgery specialist Dr. Vincent Grant, MD, practises in Lucedale, Mississippi, and he has more than 38 years of experience. In 1985, he earned his degree from the University of Alabama in Birmingham. His connection to Northern Montana Hospital is established. View Profile

In the Cumming School of Medicine's Charbonneau Cancer Center and Alberta Children's Hospital Research Institute, Dr. Douglas Mahoney works as a translational scientist. He has made significant contributions over the past 15 years to the development of numerous cancer immunotherapies that are currently being explored in human clinical trials. In order to create ""designed viruses"" that elicit anticancer immunity and enhance Chimeric Antigen Receptor (CAR) T-cell treatment of cancer, his lab is currently concentrating on understanding how rhabdoviruses interact with immune cells. His lab collaborates with top genomics and immunology labs in Alberta and uses cutting-edge synthetic biology, high-resolution in vivo imaging, and robotic screening technologies, among other approaches. A brand-new research programme named ACTION (Alberta Cellular Therapy and Immune Oncology), which was established in collaboration with the Canadian Cancer Society in 2020, has Dr. Mahoney as its Scientific Director. Doug's team at ACTION is working to create revolutionary next-generation tailored T cell treatments against fresh targets found on solid tumours with a high mortality rate. View Profile